Could a common immune treatment save lives during sudden lung scarring attacks?
Disease control
Recruiting now
This study tests whether adding intravenous immunoglobulin (IVIG) to standard care helps people hospitalized with a sudden, severe worsening of idiopathic pulmonary fibrosis (IPF). About 196 adults with IPF who are having an acute exacerbation will receive either usual treatment …
Phase: PHASE3 • Sponsor: Argyrios Tzouvelekis • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC